Intuitive Surgical, Inc. $ISRG Shares Sold by Fisher Asset Management LLC

Fisher Asset Management LLC reduced its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 1.1% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 3,876,299 shares of the medical equipment provider’s stock after selling 42,541 shares during the period. Fisher Asset Management LLC’s holdings in Intuitive Surgical were worth $1,576,220,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also bought and sold shares of the business. Fairscale Capital LLC lifted its holdings in shares of Intuitive Surgical by 3.5% in the 3rd quarter. Fairscale Capital LLC now owns 645 shares of the medical equipment provider’s stock worth $279,000 after acquiring an additional 22 shares during the last quarter. Beaumont Financial Advisors LLC boosted its stake in shares of Intuitive Surgical by 3.8% in the 3rd quarter. Beaumont Financial Advisors LLC now owns 627 shares of the medical equipment provider’s stock valued at $255,000 after purchasing an additional 23 shares in the last quarter. Hughes Financial Services LLC grew its holdings in shares of Intuitive Surgical by 40.7% during the 3rd quarter. Hughes Financial Services LLC now owns 83 shares of the medical equipment provider’s stock valued at $37,000 after purchasing an additional 24 shares during the last quarter. W.G. Shaheen & Associates DBA Whitney & Co grew its holdings in shares of Intuitive Surgical by 1.0% during the 1st quarter. W.G. Shaheen & Associates DBA Whitney & Co now owns 2,542 shares of the medical equipment provider’s stock valued at $1,172,000 after purchasing an additional 25 shares during the last quarter. Finally, Blue Fin Capital Inc. grew its holdings in shares of Intuitive Surgical by 0.5% during the 1st quarter. Blue Fin Capital Inc. now owns 4,794 shares of the medical equipment provider’s stock valued at $2,210,000 after purchasing an additional 25 shares during the last quarter. 83.64% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

A number of equities analysts recently commented on the stock. Oppenheimer reiterated an “outperform” rating and issued a $500.00 target price on shares of Intuitive Surgical in a research report on Wednesday, October 21st. HSBC lowered shares of Intuitive Surgical from a “buy” rating to a “hold” rating and set a $391.00 price target for the company. in a research report on Thursday, July 30th. Raymond James Financial reaffirmed an “outperform” rating and set a $480.00 price objective on shares of Intuitive Surgical in a research note on Wednesday, October 21st. Leerink Partners set a $503.00 price objective on Intuitive Surgical and gave the company an “outperform” rating in a research note on Wednesday, October 21st. Finally, Weiss Ratings reiterated a “hold (c)” rating on shares of Intuitive Surgical in a report on Friday, August 14th. One equities research analyst has rated the stock with a Strong Buy rating, twenty-three have issued a Buy rating, five have assigned a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $493.54.

Intuitive Surgical Stock Performance

Shares of ISRG stock opened at $439.89 on Friday. The company has a market capitalization of $152.48 billion, a P/E ratio of 53.19, a PEG ratio of 3.10 and a beta of 1.45. Intuitive Surgical, Inc. has a fifty-two week low of $328.57 and a fifty-two week high of $603.88. The stock has a 50 day moving average price of $416.12 and a two-hundred day moving average price of $430.38.

Intuitive Surgical (NASDAQ:ISRG) last issued its earnings results on Tuesday, October 20th. The medical equipment provider reported $3.00 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.65 by $0.35. Intuitive Surgical had a net margin of 25.54% and a return on equity of 18.17%. The firm had revenue of $3.05 billion for the quarter, compared to analysts’ expectations of $2.91 billion. During the same quarter last year, the business earned $2.40 earnings per share. The business’s revenue was up 21.7% on a year-over-year basis. As a group, equities analysts predict that Intuitive Surgical, Inc. will post 9.37 earnings per share for the current year.

Insider Activity at Intuitive Surgical

In related news, Director Gary Guthart sold 10,000 shares of the company’s stock in a transaction on Wednesday, November 4th. The shares were sold at an average price of $457.34, for a total transaction of $4,573,400.00. Following the completion of the sale, the director directly owned 1,194,530 shares in the company, valued at $546,306,350.20. This represents a 0.83% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Gary Loeb sold 400 shares of the stock in a transaction on Tuesday, November 10th. The shares were sold at an average price of $458.15, for a total transaction of $183,260.00. Following the sale, the executive vice president directly owned 6,236 shares of the company’s stock, valued at $2,857,023.40. The trade was a 6.03% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 39,456 shares of company stock worth $17,769,124 over the last ninety days. Insiders own 0.60% of the company’s stock.

Intuitive Surgical Profile

Intuitive Surgical develops, manufactures and markets robotic-assisted systems for minimally invasive procedures. Its products include da Vinci surgical systems, which allow surgeons to control instruments and a high-definition vision system from a console, as well as the Ion endoluminal system, designed to assist with minimally invasive lung biopsies. The company also provides instruments, accessories, training and support services for its systems. Its technology is used in a range of surgical specialties, including urology, general surgery and gynecology.